Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Simpson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Immunology, Immunotherapy : CII|March 14, 2019
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibitionVylyny Chat, Robert Ferguson, Danny Simpson, et al.
Journal of Translational Medicine|April 3, 2018
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitorsMichael F Gowen, Keith M Giles, Danny Simpson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2023
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibitionRobert Ferguson, Vylyny Chat, Leah Morales, et al.
Journal of the National Cancer Institute|June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to TherapyMichael Lattanzi, Yesung Lee, Danny Simpson, et al.
Nature|April 3, 2024
Improving prime editing with an endogenous small RNA-binding proteinJun Yan, Paul Oyler-Castrillo, Purnima Ravisankar, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Integrating multi-omic QTLs and predictive models reveals regulatory architectures at immune related GWAS loci in CD4+ T cellsMarliette R Matos, Samuel Ghatan, Sean Bankier, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Immunology, Immunotherapy : CII|March 14, 2019
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibitionVylyny Chat, Robert Ferguson, Danny Simpson, et al.
Journal of Translational Medicine|April 3, 2018
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitorsMichael F Gowen, Keith M Giles, Danny Simpson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2023
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibitionRobert Ferguson, Vylyny Chat, Leah Morales, et al.
Journal of the National Cancer Institute|June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to TherapyMichael Lattanzi, Yesung Lee, Danny Simpson, et al.
Nature|April 3, 2024
Improving prime editing with an endogenous small RNA-binding proteinJun Yan, Paul Oyler-Castrillo, Purnima Ravisankar, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Integrating multi-omic QTLs and predictive models reveals regulatory architectures at immune related GWAS loci in CD4+ T cellsMarliette R Matos, Samuel Ghatan, Sean Bankier, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Pageof 2